Anatolij Horuzsko, MD, PhD, received a 5-year, $1.6M R01 grant from NCI/NIH for “TREM-1 and Its Implications to Cancer

Anatolij Horuzsko, MD, PhD
Anatolij Horuzsko, MD, PhD
 Anatolij Horuzsko, MD, PhD
Anatolij Horuzsko, MD, PhD
A connection between inflammation and cancer has been long suspected. The Horuzsko laboratory has identified mechanisms of chronic inflammation leading to liver carcinogenesis – and that this process can be diminished by inhibiting a molecule called TREM-1 in experimental models. This R01 will support further research studying the role of TREM-1 in controlling initiation and progression of liver tumorigenesis. The knowledge gained should help develop strategies for potent anti-cancer prevention and novel clinical and preclinical therapeutic approaches that target the immune and non-immune components of liver tumors. Additionally, this research may benefit patients with a variety of inflammatory diseases, including allergy and autoimmune diseases.

Written by
Allison Brown
View all articles
Leave a reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Written by Allison Brown

About Jagwire

Jagwire is the official source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia. Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences. Have a story to share with Jaguar Nation? Contact the Division of Communications & Marketing.